New insights in preanalytical quality.

IF 3.8 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Mario Plebani, Sheri Scott, Ana-Maria Simundic, Mike Cornes, Andrea Padoan, Janne Cadamuro, Pieter Vermeersch, Hikmet Can Çubukçu, Álvaro González, Mads Nybo, Gian Luca Salvagno, Seán J Costelloe, Rosanna Falbo, Alexander von Meyer, Enrico Iaccino, Francesco Botrè, Giuseppe Banfi, Giuseppe Lippi
{"title":"New insights in preanalytical quality.","authors":"Mario Plebani, Sheri Scott, Ana-Maria Simundic, Mike Cornes, Andrea Padoan, Janne Cadamuro, Pieter Vermeersch, Hikmet Can Çubukçu, Álvaro González, Mads Nybo, Gian Luca Salvagno, Seán J Costelloe, Rosanna Falbo, Alexander von Meyer, Enrico Iaccino, Francesco Botrè, Giuseppe Banfi, Giuseppe Lippi","doi":"10.1515/cclm-2025-0478","DOIUrl":null,"url":null,"abstract":"<p><p>The negative impact of preanalytical errors on the quality of laboratory testing is now universally recognized. Nonetheless, recent technological advancements and organizational transformations in healthcare - catalyzed by the still ongoing coronavirus disease 2019 (COVID-19 pandemic) - have introduced new challenges and promising opportunities for improvement. The integration of value-based scoring systems for clinical laboratories and growing evidence linking preanalytical errors to patient outcomes and healthcare costs underscore the critical importance of this phase. Emerging topics in the preanalytical phase include the pursuit of a \"greener\" and more sustainable environment, innovations in self-sampling and automated blood collection, and strategies to minimize patient blood loss. Additionally, efforts to reduce costs and enhance sustainability through patient blood management have gained momentum. Digitalization and artificial intelligence (AI) offer transformative potential, with applications in sample labeling, recording collection events, and monitoring sample conditions during transportation. AI-driven tools can also streamline the preanalytical workflow and mitigate errors. Specific challenges include managing hemolysis and developing strategies to minimize its impact, addressing issues related to urine collection, and designing robust protocols for sample stability studies. The rise of decentralized laboratory testing presents unique preanalytical hurdles, while emerging areas such as liquid biopsy and anti-doping testing introduce novel complexities. Altogether, these advancements and challenges highlight the dynamic evolution of the preanalytical phase and the critical need for continuous innovation and standardization. This collective opinion paper, which summarizes the abstracts of lectures delivered at the two-day European Federation of Laboratory Medicine (EFLM) Preanalytical Conference entitled \"New Insight in Preanalytical Quality\" (Padova, Italy; December 12-13, 2025), provides a comprehensive overview of preanalytical errors, offers some important insights into less obvious sources of preanalytical vulnerability and proposes efficient opportunities of improvement.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2025-0478","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The negative impact of preanalytical errors on the quality of laboratory testing is now universally recognized. Nonetheless, recent technological advancements and organizational transformations in healthcare - catalyzed by the still ongoing coronavirus disease 2019 (COVID-19 pandemic) - have introduced new challenges and promising opportunities for improvement. The integration of value-based scoring systems for clinical laboratories and growing evidence linking preanalytical errors to patient outcomes and healthcare costs underscore the critical importance of this phase. Emerging topics in the preanalytical phase include the pursuit of a "greener" and more sustainable environment, innovations in self-sampling and automated blood collection, and strategies to minimize patient blood loss. Additionally, efforts to reduce costs and enhance sustainability through patient blood management have gained momentum. Digitalization and artificial intelligence (AI) offer transformative potential, with applications in sample labeling, recording collection events, and monitoring sample conditions during transportation. AI-driven tools can also streamline the preanalytical workflow and mitigate errors. Specific challenges include managing hemolysis and developing strategies to minimize its impact, addressing issues related to urine collection, and designing robust protocols for sample stability studies. The rise of decentralized laboratory testing presents unique preanalytical hurdles, while emerging areas such as liquid biopsy and anti-doping testing introduce novel complexities. Altogether, these advancements and challenges highlight the dynamic evolution of the preanalytical phase and the critical need for continuous innovation and standardization. This collective opinion paper, which summarizes the abstracts of lectures delivered at the two-day European Federation of Laboratory Medicine (EFLM) Preanalytical Conference entitled "New Insight in Preanalytical Quality" (Padova, Italy; December 12-13, 2025), provides a comprehensive overview of preanalytical errors, offers some important insights into less obvious sources of preanalytical vulnerability and proposes efficient opportunities of improvement.

分析前质量的新见解。
分析前误差对实验室检测质量的负面影响现在已得到普遍认识。尽管如此,最近医疗保健领域的技术进步和组织变革——由仍在持续的2019年冠状病毒病(COVID-19大流行)催化——带来了新的挑战和有希望的改进机会。临床实验室基于价值的评分系统的整合,以及越来越多的证据将分析前错误与患者结果和医疗成本联系起来,强调了这一阶段的关键重要性。分析前阶段的新主题包括追求“更绿色”和更可持续的环境,自我采样和自动血液采集的创新,以及减少患者失血的策略。此外,通过患者血液管理降低成本和提高可持续性的努力也取得了进展。数字化和人工智能(AI)提供了变革的潜力,应用于样品标签、记录收集事件和监测运输过程中的样品条件。人工智能驱动的工具还可以简化分析前工作流程并减少错误。具体的挑战包括管理溶血和制定策略以尽量减少其影响,解决与尿液收集相关的问题,以及为样本稳定性研究设计可靠的方案。分散实验室检测的兴起带来了独特的分析前障碍,而液体活检和反兴奋剂检测等新兴领域则带来了新的复杂性。总之,这些进步和挑战突出了分析前阶段的动态演变以及对持续创新和标准化的迫切需求。这份集体意见文件总结了在为期两天的欧洲检验医学联合会(EFLM)前分析会议上发表的演讲摘要,题为“前分析质量的新见解”(意大利帕多瓦;(12月12日至13日,2025年),提供了分析前错误的全面概述,对分析前漏洞的不太明显的来源提供了一些重要的见解,并提出了有效的改进机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry and laboratory medicine
Clinical chemistry and laboratory medicine 医学-医学实验技术
CiteScore
11.30
自引率
16.20%
发文量
306
审稿时长
3 months
期刊介绍: Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically. CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France). Topics: - clinical biochemistry - clinical genomics and molecular biology - clinical haematology and coagulation - clinical immunology and autoimmunity - clinical microbiology - drug monitoring and analysis - evaluation of diagnostic biomarkers - disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) - new reagents, instrumentation and technologies - new methodologies - reference materials and methods - reference values and decision limits - quality and safety in laboratory medicine - translational laboratory medicine - clinical metrology Follow @cclm_degruyter on Twitter!
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信